Molecular Basis for Atovaquone Binding to the Cytochrome bc 1 Complex
Open Access
- 1 August 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (33) , 31312-31318
- https://doi.org/10.1074/jbc.m304042200
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Mutations in Plasmodium falciparum Cytochrome b That Are Associated with Atovaquone Resistance Are Located at a Putative Drug-Binding SiteAntimicrobial Agents and Chemotherapy, 2000
- Characterization of cytochrome b from Toxoplasma gondii and Qo domain mutations as a mechanism of atovaquone-resistanceMolecular and Biochemical Parasitology, 2000
- Mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquoneMolecular and Biochemical Parasitology, 1999
- Resistance mutations reveal the atovaquone‐binding domain of cytochrome b in malaria parasitesMolecular Microbiology, 1999
- Sequence Polymorphisms in thePneumocystis cariniiCytochromebGene and Their Association with Atovaquone Prophylaxis FailureThe Journal of Infectious Diseases, 1998
- ENERGY TRANSDUCTION BY CYTOCHROME COMPLEXES IN MITOCHONDRIAL AND BACTERIAL RESPIRATION: The Enzymology of Coupling Electron Transfer Reactions to Transmembrane Proton TranslocationAnnual Review of Biochemistry, 1994
- Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80)Biochemical Pharmacology, 1992
- Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondiiAntimicrobial Agents and Chemotherapy, 1991
- Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitisAntimicrobial Agents and Chemotherapy, 1990
- In vitro activity of 2-alkyl-3-hydroxy-1,4-naphthoquinones against Theileria parvaJournal of Medicinal Chemistry, 1981